Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection by Lewis H Kuller (29644)

“…</p> <p> <b>Trial Registration</b>: <a href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</a> (<a href="http://www.clinicaltrials.gov/ct2/show/NCT00027352?…”

DataSheet_1_Arctic biogeochemical and optical properties of dissolved organic matter across river to sea gradients.pdf by Michael G. Novak (13582594)

“…CDOM absorption coefficient at 412 nm (a_CDOM(412)) averaged 8.23 m^-1, 5.07 m^-1, and 1.9 m^-1, respectively. …”

Metabolomics Analysis Identifies Intestinal Microbiota-Derived Biomarkers of Colonization Resistance in Clindamycin-Treated Mice by Robin L. P. Jump (591535)

“…Of 484 compounds analyzed, 146 (30%) exhibited a significant increase or decrease in concentration during clindamycin treatment followed by recovery to baseline that coincided with restoration of <i>in vivo</i> colonization resistance. …”

DataSheet_1_CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report.docx by Yao Sun (145327)

“…Over 2 months later, he experienced a relapse of the systemic disease and he received autologous murine CAR19-41BB-CD3ζ-mIL15-T cells and achieved CRi_MRD- lasting 5 months with the strongest expansion and persistence of CAR. …”

Image_1_CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report.pdf by Yao Sun (145327)

“…Over 2 months later, he experienced a relapse of the systemic disease and he received autologous murine CAR19-41BB-CD3ζ-mIL15-T cells and achieved CRi_MRD- lasting 5 months with the strongest expansion and persistence of CAR. …”

Table_1_CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report.docx by Yao Sun (145327)

“…Over 2 months later, he experienced a relapse of the systemic disease and he received autologous murine CAR19-41BB-CD3ζ-mIL15-T cells and achieved CRi_MRD- lasting 5 months with the strongest expansion and persistence of CAR. …”

Data_Sheet_1_Health Anxiety and Mental Health Outcome During COVID-19 Lockdown in Italy: The Mediating and Moderating Roles of Psychological Flexibility.PDF by Giulia Landi (9321224)

“…This study examined the mediating and moderating roles of psychological flexibility in the link between trait health anxiety and three mental health outcomes: COVID-19 peritraumatic distress, anxiety, and depression. We hypothesized that higher psychological flexibility would decrease the negative impacts of trait health anxiety on mental health outcomes. …”

Synthetic Control to Achieve Lanthanide(III)/Pyrimidine-4,6-dicarboxylate Compounds by Preventing Oxalate Formation: Structural, Magnetic, and Luminescent Properties by Javier Cepeda (1605727)

“…The characteristic luminescence of the Nd, Eu, and Tb centers is improved when moving from <b>1-Ln</b> to <b>2-Ln</b> compounds as a consequence of the decrease of the O–H oscillators. …”

Image_2_CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report.pdf by Yao Sun (145327)

“…Over 2 months later, he experienced a relapse of the systemic disease and he received autologous murine CAR19-41BB-CD3ζ-mIL15-T cells and achieved CRi_MRD- lasting 5 months with the strongest expansion and persistence of CAR. …”

PKCε translocation is involved in isoflurane preconditioning. by Xiao-E Lang (384461)

“…D. PKCε v1–2 inhibits the decrease in heart infarct size caused by isoflurane following I/R. …”

Image4_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.tif by Mariana do Rosário Souza (9751424)

DataSheet1_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.docx by Mariana do Rosário Souza (9751424)

Image1_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.tif by Mariana do Rosário Souza (9751424)

Image2_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.tif by Mariana do Rosário Souza (9751424)

Image2_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.tif by Mariana do Rosário Souza (9751424)

Image1_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.tif by Mariana do Rosário Souza (9751424)

DataSheet1_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.docx by Mariana do Rosário Souza (9751424)

Image3_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.tif by Mariana do Rosário Souza (9751424)

Image4_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.tif by Mariana do Rosário Souza (9751424)

Image3_Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?.tif by Mariana do Rosário Souza (9751424)